Michael Maeng
Overview
Explore the profile of Michael Maeng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
307
Citations
4984
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jacobsen M, Jabbari R, Grove E, Maeng M, Veien K, Hougaard M, et al.
Am Heart J
. 2025 Feb;
PMID: 40015616
Rationale: Approximately one-third of patients with myocardial infarction (MI) treated with percutaneous coronary intervention (PCI) are at high risk of bleeding side-effects when on dual antiplatelet therapy (DAPT). High bleeding...
2.
Arslani K, Engstrom T, Maeng M, Kjoller-Hansen L, Maehara A, Zhou Z, et al.
JACC Cardiovasc Imaging
. 2025 Feb;
PMID: 39998456
Background: Hemodynamically obstructive coronary plaques may contain more vulnerable plaque characteristics than nonobstructive lesions. Objectives: The authors aimed to assess whether pressure-wire-based physiologic indices in nonculprit lesions are associated with...
3.
Thrane P, Olesen K, Thim T, Gyldenkerne C, Hansen M, Stodkilde-Jorgensen N, et al.
JACC Adv
. 2025 Feb;
4(3):101614.
PMID: 39983611
Background: Primary percutaneous coronary intervention (pPCI) has been the national reperfusion strategy for patients with ST-segment elevation myocardial infarction (STEMI) in Denmark since 2003. We recently reported a gradual reduction...
4.
Stalikas N, Bouisset F, Mizukami T, Tajima A, Munhoz D, Ikeda K, et al.
Int J Cardiovasc Imaging
. 2025 Feb;
PMID: 39971841
Background: Coronary CT Angiography (CTA) is increasingly being used to plan percutaneous coronary intervention (PCI), offering detailed pre-procedural anatomical and physiological insights. The Precise Procedural and PCI Plan (P4) study...
5.
Stodkilde-Jorgensen N, Olesen K, Gyldenkerne C, Hansen M, Nielsen R, Nielsen J, et al.
Europace
. 2025 Feb;
27(2).
PMID: 39960891
No abstract available.
6.
Gyldenkerne C, Olesen K, Thrane P, Hansen M, Stodkilde-Jorgensen N, Andersen M, et al.
Clin Epidemiol
. 2024 Dec;
16:825-836.
PMID: 39619160
The Western Denmark Heart Registry (WDHR) is a semi-national, multicenter-based clinical registry with unique potential for cardiovascular research. The registry has provided detailed prospectively registered information on patient and procedure...
7.
Gyldenkerne C, Kahlert J, Thrane P, Olesen K, Mortensen M, Sorensen H, et al.
J Am Coll Cardiol
. 2024 Nov;
84(23):2251-2259.
PMID: 39603746
Background: The risk of cardiovascular disease (CVD) is increased in individuals with type 2 diabetes mellitus (T2DM), but it remains uncertain how long an elevated CVD occurrence precedes diabetes diagnosis....
8.
Gyldenkerne C, Olesen K, Thrane P, Hansen M, Stodkilde-Jorgensen N, Sorensen H, et al.
Diabetes Care
. 2024 Nov;
48(1):76-83.
PMID: 39546433
Objective: To examine trends in peripheral artery disease (PAD), lower-extremity (LE) revascularization, and LE amputation in patients with incident type 2 diabetes. Research Design And Methods: This cohort study included...
9.
Jakobsen L, Christiansen E, Freeman P, Kahlert J, Veien K, Maeng M, et al.
Am J Cardiol
. 2024 Oct;
235():1-8.
PMID: 39461401
In-stent restenosis (ISR) still occurs after percutaneous coronary intervention (PCI). Few studies have compared the outcomes of PCI for de novo stenosis with those of PCI for ISR, and the...
10.
Byrne R, Colleran R, Coughlan J, Jauhar R, Maillard L, De Labriolle A, et al.
Circ Cardiovasc Interv
. 2024 Oct;
17(10):e013735.
PMID: 39405373
Background: Patients with an indication for oral anticoagulation who undergo percutaneous coronary intervention require a combination of oral anticoagulation and antiplatelet therapy. The use of a coronary stent with a...